ArticleFrontiers in pediatrics2026
Robotic-assisted surgery as an enabling technology for ovarian-sparing management in pediatric benign ovarian tumours: a comparative study.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Preservation of ovarian function is a major objective in the surgical management of benign ovarian tumours in pediatric and adolescent patients. Robotic-assisted surgery may facilitate ovarian-sparing procedures by improving surgical precision and dissection capabilities. This study aimed to evaluate the feasibility and perioperative safety of robotic-assisted ovarian-sparing surgery and to compare outcomes with a pre-robotic cohort. Methods: A single-centre retrospective comparative cohort study was conducted at a tertiary pediatric referral centre. Consecutive patients aged ≤18 years undergoing surgery for radiologically suspected benign ovarian tumours between January 2023 and December 2025 were included. Patients were divided into a pre-robotic cohort (2023-2024) and a robotic cohort (2025). The primary outcome was the rate of ovarian-sparing surgery. Secondary outcomes included conversion to open surgery, operative time, length of hospital stay (LOS), postoperative complications, reoperation, and postoperative analgesic consumption. Results: Twenty-four patients were included: 14 in the pre-robotic cohort and 10 in the robotic cohort. Baseline demographic characteristics were comparable between groups. Ovarian-sparing surgery was achieved in all robotic cases (100%) compared with 85.7% in the pre-robotic cohort. No conversions to open surgery occurred in the robotic group, whereas two conversions/oophorectomies occurred in the pre-robotic cohort. Operative time was longer in the robotic cohort (median 2:27:30 vs. 1:42:00; Conclusions: Robotic-assisted ovarian-sparing surgery for benign ovarian tumours in pediatric and adolescent patients is feasible and safe. Robotic technology may facilitate fertility-preserving surgery by supporting precise tumour enucleation and consistent preservation of healthy ovarian tissue, particularly in technically demanding cases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.